Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00299897
What this trial is testing

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Who this might be right for
HIV InfectionsHuman Immunodeficiency Virus
Samaritan Pharmaceuticals, Inc 60
Large-scale testing (Phase 3)Study completedNCT01939197
What this trial is testing

A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 318
Not applicableLooking for participantsNCT07226323
What this trial is testing

Testing the WeCare Intervention to Address Mental Health and Medication Adherence Challenges Among MSM in South Africa

Who this might be right for
HIV InfectionsMental Health
Emory University 60
Not applicableStudy completedNCT02626286
What this trial is testing

Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan Africa

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 885
Testing effectiveness (Phase 2)UnknownNCT00131560
What this trial is testing

Safety and Efficacy of T Cell Genetic Immunotherapy for HIV

Who this might be right for
HIV Infection
VIRxSYS Corporation 60
Testing effectiveness (Phase 2)Study completedNCT06437223
What this trial is testing

Study of Xiflam™ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC)

Who this might be right for
Long COVID
Inflammx Therapeutics Inc 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07545746
What this trial is testing

Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya

Who this might be right for
HIV InfectionsHPV InfectionCervix Cancer+7 more
UNC Lineberger Comprehensive Cancer Center 140
Not applicableUnknownNCT05140603
What this trial is testing

Ambispective Cohort Study to Evaluate the Efficacy, Safety, and Tolerance of an Antiretroviral Regimen With Doravirine

Who this might be right for
Hiv
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 150
Testing effectiveness (Phase 2)Study completedNCT00002003
What this trial is testing

Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinHIV Infections
Lederle Laboratories
Not applicableStudy completedNCT05371327
What this trial is testing

Community Solutions to Adolescent Research Consent - Minor Consent for Biomedical HIV Research

Who this might be right for
Informed ConsentHIV Infections
Indiana University 128
Early research (Phase 1)Study completedNCT00002373
What this trial is testing

The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Glaxo Wellcome 56
Large-scale testing (Phase 3)Study completedNCT02660905
What this trial is testing

HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection

Who this might be right for
Human Immunodeficiency VirusHepatitis C, Chronic
Ottawa Hospital Research Institute 25
Not applicableStudy completedNCT01048671
What this trial is testing

Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 482
Not applicableStudy completedNCT01886404
What this trial is testing

EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients

Who this might be right for
HIV Infection
University of Nebraska 30
Testing effectiveness (Phase 2)Study completedNCT00333684
What this trial is testing

Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid

Who this might be right for
Human Immunodeficiency VirusFacial Lipoatrophy
Canadian Immunodeficiency Research Collaborative 36
Testing effectiveness (Phase 2)Study completedNCT00461552
What this trial is testing

Therapeutic Approaches to HAART-Induced Lipodystrophy

Who this might be right for
HIV InfectionsLipodystrophy
University of Texas Southwestern Medical Center 23
Not applicableStudy completedNCT01413152
What this trial is testing

Residual Risk Assessment Of HIV Transmission

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 167
Not applicableStudy completedNCT00006444
What this trial is testing

The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women

Who this might be right for
HIV InfectionsPapilloma
National Institute of Allergy and Infectious Diseases (NIAID) 160
Testing effectiveness (Phase 2)Study completedNCT00035893
What this trial is testing

The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART

Who this might be right for
HIV SeropositivityHIV Infection
AIM ImmunoTech Inc. 40
Not applicableStudy completedNCT05084716
What this trial is testing

Pre-Exposure Prophylaxis (PrEP) Provision for Ugandan Fisherfolk

Who this might be right for
HIV
RAND 885
Next Page